NCT01174732View on ClinicalTrials.gov

Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

January 31, 2011

Conditions
AsthmaBronchospasm
Interventions
DRUG

albuterol inhalation powder

A006 albuterol inhalation powder, 120 mcg/inhalation, one inhalation

DRUG

albuterol inhalation powder

A006 albuterol inhalation powder, 180 mcg/inhalation, 1 inhalation

DRUG

albuterol inhalation powder

A006 albuterol inhalation powder, 120 mcg/inhalation, 2 inhalations

DRUG

albuterol inhalation powder

A006 albuterol inhalation powder, 180 mcg/inhalation, 2 inhalations

DRUG

Placebo

placebo, lactose inhalation carrier

DRUG

albuterol inhalation aerosol

albuterol inhalation aerosol, 90 mcg/inhalation, 2 inhalations

DRUG

albuterol inhalation aerosol

albuterol inhalation aerosol, 90 mcg/inhalation, 4 inhalations

Trial Locations (4)

80112

Amphastar Site 0007, Centennial

80230

Amphastar Site 0008, Denver

80401

Amphastar Site 0039, Lakewood

95117

Amphastar Site 0001, San Jose

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY